Experiences in recruiting volunteers through community based initiatives in Phase-1 vaccine trials in India

References

• NBAC. (2010). National Bioethics Advisory Commission (US) Report:Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries. Bethesda, MD: NBAC 1.
   Google Scholar
• Duke S, Bennett H. Review: a narrative review of the published ethical debates in palliative care research and an assessment of their adequacy to inform research governance. Palliat Med 2010; 24:111 - 26; http://dx.doi.org/10.1177/0269216309352714; PMID: 19965950
   PubMed Web of Science ®Google Scholar
• Vellinga A, Cormican M, Hanahoe B, Bennett K, Murphy AW. Opt-out as an acceptable method of obtaining consent in medical research: a short report. BMC Med Res Methodol 2011; 11:40; http://dx.doi.org/10.1186/1471-2288-11-40; PMID: 21470399
   PubMed Web of Science ®Google Scholar
• Murray E, Pollack L, White M, Lo B. Clinical decision-making: Patients’ preferences and experiences. Patient Educ Couns 2007; 65:189 - 96; http://dx.doi.org/10.1016/j.pec.2006.07.007; PMID: 16956742
   PubMed Web of Science ®Google Scholar
• Kaleebu P. (2005) HIV vaccine trials in Uganda: Personal experiences as an investigator. In: P. Kahn(ed.) AIDS Vaccine Handbook: Global Perspectives New York. AIDS Vaccine Action Coalition, pp. 145–151, http://www.avac.org/ht/d/sp/i/2311/pid/2311
   Google Scholar
• Lindegger G, Richter LM. HIV vaccine trials: critical issues in informed consent. S Afr J Sci 2000; 96:313 - 7; PMID: 15739286
   PubMed Web of Science ®Google Scholar
• Sahay S, Mehendale S, Sane S, Brahme R, Brown A, Charron K, Beyrer C, Bollinger R, Paranjape R. Correlates of HIV vaccine trial participation: an Indian perspective. Vaccine 2005; 23:1351 - 8; http://dx.doi.org/10.1016/j.vaccine.2004.09.032; PMID: 15661383
   PubMed Web of Science ®Google Scholar
• Ramanathan VD, Kumar M, Mahalingam J, Sathyamoorthy P, Narayanan PR, Solomon S, Panicali D, Chakrabarty S, Cox J, Sayeed E, et al. A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers. AIDS Res Hum Retroviruses 2009; 25:1107 - 16; http://dx.doi.org/10.1089/aid.2009.0096; PMID: 19943789
   PubMed Web of Science ®Google Scholar
• Mehendale S, Sahay S, Thakar M, Sahasrabuddhe S, Kakade M, Shete A, Shrotri A, Spentzou A, Tarragona T, Stevens G, et al. Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India. Indian J Med Res 2010; 132:168 - 75; PMID: 20716817
   PubMed Web of Science ®Google Scholar
• Mehendale S, Thakar M, Sahay S, Kumar M, Shete A, Sathyamurthi P, Verma A, Kurle S, Shrotri A, Gilmour J, et al. Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers. PLoS One 2013; 8:e55831; http://dx.doi.org/10.1371/journal.pone.0055831; PMID: 23418465
   PubMed Web of Science ®Google Scholar
• Woodsong C, Macqueen K, Namey E, Sahay S, Morar N, Mlingo M, Mehendale S. Women’s Autonomy and Informed Consent in Microbicides Clinical Trials. J Empir Res Hum Res Ethics 2006; 1:11 - 26; http://dx.doi.org/10.1525/jer.2006.1.3.11; PMID: 19385819
   PubMed Web of Science ®Google Scholar
• Freire P. (1983). Pedagogy of the Oppressed, New York: Continuum.
   Google Scholar
• Mehendale S. Acquired immune deficiency syndrome vaccine trials: Managing ethical issues before, during and after the trials. Perspect Clin Res 2013; 4:84 - 8; http://dx.doi.org/10.4103/2229-3485.106401; PMID: 23533989
   PubMedGoogle Scholar
• Moutsiakis DL, Chin PN. Why blacks do not take part in HIV vaccine trials. J Natl Med Assoc 2007; 99:254 - 7; PMID: 17393949
   PubMed Web of Science ®Google Scholar
• Harro CD, Judson FN, Gorse GJ, Mayer KH, Kostman JR, Brown SJ, Koblin B, Marmor M, Bartholow BN, Popovic V, VAX004 Study Group. Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2004; 37:1385 - 92; http://dx.doi.org/10.1097/01.qai.0000122983.87519.b5; PMID: 15483468
   PubMed Web of Science ®Google Scholar
• Luzi AM, Gallo P, Colucci A, Marcotullio S, Bellino S, Longo O, Ensoli B. Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein. AIDS Care 2011; 23:939 - 46; http://dx.doi.org/10.1080/09540121.2010.542124; PMID: 21390884
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2000). “Ethical considerations in HIV preventive vaccine research: UNAIDS guidance document.” 3rd Reprint April 2004. Retrieved 11 September, 2013, from http://www.who.int/rpc/research_ethics/jc072-ethicalcons_en_pdf.pdf.
   Google Scholar
• Mehendale S, Sahay S, Thakar M, Sahasrabuddhe S, Kakade M, Shete A, Shrotri A, Spentzou A, Tarragona T, Stevens G, et al. Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India. Indian J Med Res 2010; 132:168 - 75; PMID: 20716817
   PubMed Web of Science ®Google Scholar
• Jenkins RA, Chinaworapong S, Morgan PA, Ruangyuttikarn C, Sontirat A, Chiu J, Michael RA, Nitayaphan S, Khamboonruang C. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:171 - 7; http://dx.doi.org/10.1097/00042560-199806010-00009; PMID: 9637582
   PubMedGoogle Scholar
• Sahay S, Mehendale S. Engaging community to support HIV prevention research. East J Med 2011; 16:168 - 77; PMID: 23807866
   PubMedGoogle Scholar
• Woodsong C, Alleman P, Musara P, Chandipwisa A, Chirenje M, Martinson F, Hoffman I. Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe. AIDS Behav 2012; 16:785 - 90; http://dx.doi.org/10.1007/s10461-011-0027-7; PMID: 21863339
   PubMed Web of Science ®Google Scholar
• Nappo SA, Iafrate GB, Sanchez ZM. Motives for participating in a clinical research trial: a pilot study in Brazil. BMC Public Health 2013; 13:19; http://dx.doi.org/10.1186/1471-2458-13-19; PMID: 23302375
   PubMed Web of Science ®Google Scholar
• Koen J, Essack Z, et al. (2012). “'It Looks Like You Just Want Them When Things Get Rough': Civil Society Perspectives on Negative Trial Results and Stakeholder Engagement in HIV Prevention Trials.” Dev World Bioeth. doi: http://dx.doi.org/10.1111/j.1471-8847.2012.00338.x. [Epub ahead of print].
   Google Scholar
• Bharat S, Aggleton P. Facing the challenge: household responses to HIV/AIDS in Mumbai, India. AIDS Care 1999; 11:31 - 44; http://dx.doi.org/10.1080/09540129948180; PMID: 10434981
   PubMed Web of Science ®Google Scholar
• Mawar N, Saha S, Pandit A, Mahajan U. The third phase of HIV pandemic: social consequences of HIV/AIDS stigma & discrimination & future needs. Indian J Med Res 2005; 122:471 - 84; PMID: 16517997
   PubMed Web of Science ®Google Scholar
• Steward WT, Herek GM, Ramakrishna J, Bharat S, Chandy S, Wrubel J, Ekstrand ML. HIV-related stigma: adapting a theoretical framework for use in India. Soc Sci Med 2008; 67:1225 - 35; http://dx.doi.org/10.1016/j.socscimed.2008.05.032; PMID: 18599171
   PubMed Web of Science ®Google Scholar
• Frew PM, del Rio C, Lu L, Clifton S, Mulligan MJ. Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial. J Acquir Immune Defic Syndr 2009; 50:314 - 9; http://dx.doi.org/10.1097/QAI.0b013e3181945eec; PMID: 19194310
   PubMed Web of Science ®Google Scholar
• Pinnow E, Sharma P, Parekh A, Gevorkian N, Uhl K. Increasing participation of women in early phase clinical trials approved by the FDA. Womens Health Issues 2009; 19:89 - 93; http://dx.doi.org/10.1016/j.whi.2008.09.009; PMID: 19272558
   PubMed Web of Science ®Google Scholar
• Asiki G, Abaasa A, Ruzagira E, Kibengo F, Bahemuka U, Mulondo J, Seeley J, Bekker LG, Delany S, Kaleebu P, et al. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. Vaccine 2013; 31:5055 - 61; http://dx.doi.org/10.1016/j.vaccine.2013.08.080; PMID: 24021306
   PubMed Web of Science ®Google Scholar
• Decker KM, Turner D, Demers AA, Martens PJ, Lambert P, Chateau D. Evaluating the effectiveness of cervical cancer screening invitation letters. J Womens Health (Larchmt) 2013; 22:687 - 93; http://dx.doi.org/10.1089/jwh.2012.4203; PMID: 23915107
   PubMed Web of Science ®Google Scholar
• Mills EN, Nixon S, Singh S, Dolma S, Nayyar A, Kapoor S. Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge. PLoS Med 2006; 3:e94; http://dx.doi.org/10.1371/journal.pmed.0030094; PMID: 16478295
   PubMed Web of Science ®Google Scholar
• Hadidi N, Lindquist R, Treat-Jacobson D, Swanson P. Participant withdrawal: challenges and practical solutions for recruitment and retention in clinical trials. Creat Nurs 2013; 19:37 - 41; http://dx.doi.org/10.1891/1078-4535.19.1.37; PMID: 23600026
   PubMedGoogle Scholar
• Chakrapani V, Newman PA, Singhal N, Nelson R, Shunmugam M. “If It’s Not Working, Why Would They Be Testing It?”: mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India. BMC Public Health 2013; 13:731; http://dx.doi.org/10.1186/1471-2458-13-731; PMID: 23919283
   PubMed Web of Science ®Google Scholar
• Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, Koblin B, Gurwith M, Bartholow B. Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005; 39:359 - 64; http://dx.doi.org/10.1097/01.qai.0000152039.88422.ec; PMID: 15980699
   PubMed Web of Science ®Google Scholar
• Dhalla S, Poole G. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. AIDS Care 2011; 23:1430 - 47; http://dx.doi.org/10.1080/09540121.2011.555750; PMID: 21722022
   PubMed Web of Science ®Google Scholar
• Carlet J, Thijs LG, Antonelli M, Cassell J, Cox P, Hill N, Hinds C, Pimentel JM, Reinhart K, Thompson BT. Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003. Intensive Care Med 2004; 30:770 - 84; http://dx.doi.org/10.1007/s00134-004-2241-5; PMID: 15098087
   PubMed Web of Science ®Google Scholar
• Davidson JE, Powers K, Hedayat KM, Tieszen M, Kon AA, Shepard E, Spuhler V, Todres ID, Levy M, Barr J, et al, American College of Critical Care Medicine Task Force 2004-2005, Society of Critical Care Medicine. Clinical practice guidelines for support of the family in the patient-centered intensive care unit: American College of Critical Care Medicine Task Force 2004-2005. Crit Care Med 2007; 35:605 - 22; http://dx.doi.org/10.1097/01.CCM.0000254067.14607.EB; PMID: 17205007
   PubMed Web of Science ®Google Scholar
• Mercurio MR, Forman EN, Ladd RE, Maxwell MA, Ross LF, Silber TJ, American Academy of Pediatrics Section on Bioethics. American academy of pediatrics policy statements on bioethics: summaries and commentaries: part 3. Pediatr Rev 2008; 29:e28 - 34; http://dx.doi.org/10.1542/pir.29-5-e28; PMID: 18450835
   PubMedGoogle Scholar
• Kon AA. The shared decision-making continuum. JAMA 2010; 304:903 - 4; http://dx.doi.org/10.1001/jama.2010.1208; PMID: 20736477
   PubMed Web of Science ®Google Scholar
• Beauchamp TL, Childress JF. (2001). Principles of Biomedical Ethics. Oxford and New York, Oxford University Press.
   Google Scholar
• Donchin A. (2000). “Autonomy and Interdependence: Quandaries in Genetic Decision Making.” In Relational Autonomy: Feminist Perspectives on Autonomy, Agency, and the Social Self Oxford, Oxford University Press.
   Google Scholar